North America extended its dominance for artificial intelligence (AI) hiring among pharmaceutical industry companies in the three months ending January.
The number of roles in North America made up 48.6 per cent of total AI jobs – up from 46.1 per cent in the same quarter in 2020.
That was followed by Asia-Pacific, which saw a 2.4 year-on-year percentage point change in AI roles.
The figures are compiled by GlobalData, who track the number of new job postings from key companies in various sectors over time. Using textual analysis, these job advertisements are then classified thematically.
GlobalData's thematic approach to sector activity seeks to group key company information by topic to see which companies are best placed to weather the disruptions coming to their industries.
These key themes, which include artificial intelligence, are chosen to cover "any issue that keeps a CEO awake at night".
By tracking them across job advertisements it allows us to see which companies are leading the way on specific issues and which are dragging their heels - and importantly where the market is expanding and contracting.
Which countries are seeing the most growth for AI job ads in the pharmaceutical industry?
The fastest growing country was India, which saw 3.1 per cent of all AI job adverts in the three months ending January 2020, increasing to 6.2 per cent in the three months ending January last year.
That was followed by the United States (up 2.5 percentage points), France (up 1.4), and Italy (up -0.6).
The top country for AI roles in the pharmaceutical industry is the United States which saw 48.6 per cent of all roles advertised in the three months ending January.
Which cities are the biggest hubs for AI workers in the pharmaceutical industry?
Some 6.4 per cent of all pharmaceutical industry AI roles were advertised in Cambridge (United States) in the three months ending January - more than any other city.
That was followed by Cambridge (United Kingdom) with 6.4 per cent, Bengaluru (India) with 2.6 per cent, and Boston (United States) with 1.9 per cent.